Lisa Bowen, NP
Nurse Practitioner · Alexandria, VANPI 1801430053
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 31.5% of the total. Reporting peaked in 2021 at $1,581 and has fallen 99.1% since, to $14 in 2025. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 137 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$786
- Novo Nordisk$196
- Esperion Therapeutics, Inc.$185
- Amgen$143
- AstraZeneca$122
- Pfizer$120
- plus $939 from 17 others
What the payments were for
- Food & beverage$2,492100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $786 |
| Novo Nordisk | 10 | $196 |
| Esperion Therapeutics, Inc. | 9 | $185 |
| Amgen(2 entities) | 8 | $143 |
| AstraZeneca | 7 | $122 |
| Pfizer | 8 | $120 |
| Merck | 7 | $108 |
| Johnson & Johnson | 3 | $81 |
| Amarin Pharma, Inc. | 4 | $81 |
| Biohaven Pharmaceuticals, Inc. | 4 | $77 |
| GSK | 4 | $77 |
| Novartis | 4 | $69 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Seqirus USA Inc | 4 | $65 |
| Paratek Pharmaceuticals, Inc. | 3 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $48 |
| Lilly USA, LLC | 3 | $47 |
| Kaleo, Inc. | 3 | $44 |
| Boehringer Ingelheim | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Eisai Inc. | 1 | $14 |
How this compares
$2,492 in reported general payments places this provider in the 90th percentile of 2,166 nurse practitioner providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Alexandria
- Ashley CarmenAlexandria$99K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Rachel AndersonCharlottesville$90K
- Megan FrancisArlington$81K
- Elizabeth WilletteNorfolk$58K
- Lacey LyleSuffolk$50K
- Kristin AustriaVirginia Beach$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.